| Home : March 2015 : March 06, 2015 News : SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Pharmacyclics, Inc. - PCYC |
SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Pharmacyclics, Inc. - PCYC |
March 06, 2015
NEW YORK, March 5, 2015 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pharmacyclics, Inc. ("Pharmacyclics" or the "Company") (NASDAQ: PCYC) (ISIN: US7169331060) (CUSIP: 716933106) concerning the proposed acquisition of Pharmacyclics by AbbVie...
http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-llp-investigates-claims-that-the-merger-may-not-be-in-the-best-interest-of-investors-of-pharmacyclics-inc---pcyc-300046232.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
